Bare Financial Services
AXSM icon

Bare Financial Services’s Axsome Therapeutics AXSM Stock Holding History

Bare Financial Services’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.95K Hold
16
– – ﹤0.01% 1091
2026
Q2 		$3.92K Hold
16
– – ﹤0.01% 943
2026
Q1 		$2.7K Hold
16
– – ﹤0.01% 879
2025
Q4 		$2.92K Sell
16
-5
-24% -$698 ﹤0.01% 736
2025
Q3 		$2.55K Buy
21
+11
+110% +$1.24K ﹤0.01% 751
2025
Q2 		$1.04K Buy
+10
New +$1.06K ﹤0.01% 912

Other funds holding AXSM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Bare Financial Services's AXSM Position: Q3 2026 in Review

Bare Financial Services held its Axsome Therapeutics (AXSM) position steady in Q3 2026 at 16 shares worth $2.95K. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

Bare Financial Services first reported a position in AXSM in Q2 2025 and has held it in 6 quarters since. The position peaked at $3.92K in Q2 2026. 206 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Bare Financial Services held 16 shares of Axsome Therapeutics worth $2.95K as of Q3 2026.
  • Bare Financial Services left its Axsome Therapeutics share count unchanged in Q3 2026.
  • Axsome Therapeutics made up ﹤0.01% of Bare Financial Services's portfolio in Q3 2026, its #1091 holding.
  • Bare Financial Services first reported a position in Axsome Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • Bare Financial Services's Axsome Therapeutics position peaked at $3.92K in Q2 2026.
  • 206 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Bare Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.